200 related articles for article (PubMed ID: 26981643)
1. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.
Kushwaha A; Shivakumar HN; Murthy SN
Drug Dev Ind Pharm; 2016 Oct; 42(10):1678-82. PubMed ID: 26981643
[TBL] [Abstract][Full Text] [Related]
2. Iontophoresis across the proximal nail fold to target drugs to the nail matrix.
Manda P; Sammeta SM; Repka MA; Murthy SN
J Pharm Sci; 2012 Jul; 101(7):2392-7. PubMed ID: 22487899
[TBL] [Abstract][Full Text] [Related]
3. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
[TBL] [Abstract][Full Text] [Related]
4. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
Nair AB; Vaka SR; Murthy SN
Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
[TBL] [Abstract][Full Text] [Related]
5. Trans-ungual iontophoretic delivery of terbinafine.
Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
Nair AB; Sammeta SM; Kim HD; Chakraborty B; Friden PM; Murthy SN
Int J Pharm; 2009 Jun; 375(1-2):22-7. PubMed ID: 19481686
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.
Amichai B; Mosckovitz R; Trau H; Sholto O; Ben-Yaakov S; Royz M; Barak D; Nitzan B; Shemer A
Mycopathologia; 2010 May; 169(5):343-9. PubMed ID: 20012894
[TBL] [Abstract][Full Text] [Related]
8. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
9. An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.
Nair AB; Kim HD; Davis SP; Etheredge R; Barsness M; Friden PM; Murthy SN
Pharm Res; 2009 Sep; 26(9):2194-201. PubMed ID: 19582550
[TBL] [Abstract][Full Text] [Related]
10. Iontophoretic drug delivery across the nail.
Delgado-Charro MB
Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
[TBL] [Abstract][Full Text] [Related]
11. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
12. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.
Nair AB; Chakraborty B; Murthy SN
Curr Drug Deliv; 2010 Dec; 7(5):407-14. PubMed ID: 20955143
[TBL] [Abstract][Full Text] [Related]
13. Trans-ungual delivery of itraconazole hydrochloride by iontophoresis.
Kushwaha A; Jacob M; Shiva Kumar HN; Hiremath S; Aradhya S; Repka MA; Murthy SN
Drug Dev Ind Pharm; 2015; 41(7):1089-94. PubMed ID: 25482587
[TBL] [Abstract][Full Text] [Related]
14. Studies in drug transport vs. current in iontophoretic onychomycosis treatment.
Barsness M; Davis SP; Etheredge R; Chang K; Kim H
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():289-94. PubMed ID: 19964736
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
Amichai B; Nitzan B; Mosckovitz R; Shemer A
Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
Patel MM; Vora ZM
Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
18. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
19. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
[TBL] [Abstract][Full Text] [Related]
20. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.
Tanrıverdi ST; Özer Ö
Eur J Pharm Sci; 2013 Mar; 48(4-5):628-36. PubMed ID: 23295582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
